Company Filing History:

29 out of 1,858

Takeda Chemical Industries, Inc.

patents

9 out of 1,177

Takeda Pharmaceutical Company Limited

patents

Years Active: 1993-2011

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8067453 - Neurotrophin production/secretion promoting agent (2011-11-29),

2. 7423159 - Agent for preventing or treating neuropathy (2008-09-09),

3. 7396848 - Neurotrophin production/secretion promoting agent (2008-07-08),

4. 7368578 - Five-membered heterocyclic compounds (2008-05-06),

5. 7241785 - Five-membered heterocyclic alkanoic acid derivative (2007-07-10),

6. 7238716 - Alkanoic acid derivatives process for their production and use thereof (2007-07-03),

7. 7183276 - Azole compounds (2007-02-27),

8. 7179823 - 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity (2007-02-20),

9. 7022725 - Isoxazole derivatives (2006-04-04),

10. 6924300 - Oxyiminoalkanoic acid derivatives (2005-08-02),

11. 6777435 - Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics (2004-08-17),

12. 6605629 - Neurotrophin production secretion promoting agent (2003-08-12),

13. 6555565 - Apoptosis inhibitor (2003-04-29),

14. 6552058 - Oxazolidinedione derivatives and their use (2003-04-22),

15. 6545009 - Retinoid-related receptor function regulating agent (2003-04-08),

Title: The Innovative Contributions of Yu Momose in Neuropharmacology

Introduction

Yu Momose, an accomplished inventor based in Takarazuka, Japan, has made significant strides in the field of neuropharmacology with a total of 38 patents to his name. His inventions are particularly focused on agents that promote neurotrophin production and provide solutions for preventing or treating neuropathy, showcasing a commitment to improving neurological health.

Latest Patents

Among his latest innovations, Yu has developed a neurotrophin production/secretion promoting agent characterized by a specific azole derivative formula. This compound includes versatile substituents such as halogen atoms and various functional groups, making it an effective candidate for preventing or treating neuropathy. Another noteworthy patent outlines an agent designed to address neuropathy effectively while maintaining low toxicity. This invention employs a unique compound involving a 5-membered aromatic heterocycle and has potential applications in enhancing patient care.

Career Highlights

Throughout his career, Yu Momose has worked extensively with reputable organizations such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His expertise in pharmaceutical research has propelled him to the forefront of neuropharmacological innovation.

Collaborations

Yu has collaborated with esteemed colleagues, including Takashi Sohda and Hiroyuki Odaka, enriching the research landscape with expertise and collective insights. These collaborations have underpinned many of his innovative projects, driving advancements in the treatment of neurological conditions.

Conclusion

The contributions of Yu Momose to the field of neuropharmacology are noteworthy and impactful. His innovative patents, along with his collaborations with other researchers, pave the way for new treatments in neuropathy and neurotrophin production. As he continues to innovate, the medical community eagerly anticipates the potential benefits of his future discoveries.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.